These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17539941)

  • 1. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
    Kalita J; Misra UK; Yadav RK
    Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
    Wadwekar V; Kalita J; Misra UK
    Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of clinically atypical with typical chronic inflammatory demyelinating polyradiculoneuropathy.
    Misra UK; Kalita J; Yadav RK
    Eur Neurol; 2007; 58(2):100-5. PubMed ID: 17565223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of intravenous immunoglobulin in CIDP.
    Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
    Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prevalence of CIDP and the association of diabetes mellitus.
    Laughlin RS; Dyck PJ; Melton LJ; Leibson C; Ransom J; Dyck PJ
    Neurology; 2009 Jul; 73(1):39-45. PubMed ID: 19564582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus.
    Münch C; Anagnostou P; Meyer R; Haas J
    J Neurol Sci; 2007 May; 256(1-2):100-2. PubMed ID: 17382963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
    Cirillo G; Todisco V; Tedeschi G
    Clin Neurophysiol; 2018 May; 129(5):967-973. PubMed ID: 29554579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical electrodiagnostic value of F-wave studies in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Varanasi S
    Clin Neurophysiol; 2013 Jan; 124(1):171-5. PubMed ID: 22748564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G; Pestronk A; Al-Lozi M
    Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study.
    Dunnigan SK; Ebadi H; Breiner A; Katzberg HD; Barnett C; Perkins BA; Bril V
    PLoS One; 2014; 9(2):e89344. PubMed ID: 24586703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
    De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
    J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A quadriplegic patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who responded well to corticosteroids and intravenous immunoglobulin therapy].
    Fukae J; Okuma Y; Noda K; Fujishima K; Goto K; Mizuno Y
    No To Shinkei; 2001 Dec; 53(12):1115-8. PubMed ID: 11806118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Shah RS
    Muscle Nerve; 2010 Aug; 42(2):252-6. PubMed ID: 20544936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
    Abraham A; Alabdali M; Qrimli M; Albulaihe H; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    PLoS One; 2015; 10(10):e0139674. PubMed ID: 26461125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
    Névoret ML; Vinik AI
    J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
    Abraham A; Breiner A; Katzberg HD; Lovblom LE; Perkins BA; Bril V
    Expert Rev Clin Immunol; 2015 Apr; 11(4):537-46. PubMed ID: 25764107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological characteristics of polyneuropathy in POEMS syndrome: comparison with CIDP.
    Cui RT; Huang XS; Liu JX; Chen ZH; Pu CQ
    J Clin Neurophysiol; 2012 Aug; 29(4):345-8. PubMed ID: 22854769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 2-limb versus 3-limb electrodiagnostic studies in the evaluation of chronic inflammatory demyelinating polyneuropathy.
    Vo ML; Hanineva A; Chin RL; Carey BT; Latov N; Langsdorf JA
    Muscle Nerve; 2015 Apr; 51(4):549-53. PubMed ID: 25131219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.